Detalhe da pesquisa
1.
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.
N Engl J Med
; 389(14): 1263-1272, 2023 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792612
2.
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial.
Lancet
; 403(10429): 850-859, 2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38364841
3.
Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseases.
J Infect Dis
; 228(Suppl 1): S13-S23, 2023 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37539758
4.
Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis.
N Engl J Med
; 383(16): 1511-1521, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33053283
5.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
Ann Rheum Dis
; 82(1): 3-18, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36357155
6.
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.
Ann Rheum Dis
; 82(6): 773-787, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35953263
7.
Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy.
Rheumatology (Oxford)
; 62(1): 89-97, 2022 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579338
8.
Anti-SARS-CoV-2 mRNA vaccines as inducers of humoral response against apolipoprotein A-1?
Eur J Clin Invest
; 52(2): e13713, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34841527
9.
Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort.
Ann Rheum Dis
; 80(2): 238-241, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32963052
10.
Associations between serum antibodies to periodontal pathogens and preclinical phases of rheumatoid arthritis.
Rheumatology (Oxford)
; 60(10): 4755-4764, 2021 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512428
11.
Effect of disease duration and other characteristics on efficacy outcomes in clinical trials of tocilizumab for rheumatoid arthritis.
Rheumatology (Oxford)
; 60(2): 682-691, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32844216
12.
Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study).
Rheumatology (Oxford)
; 60(11): 5318-5328, 2021 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33738492
13.
Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial.
Ann Rheum Dis
; 79(8): 1090-1097, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32404342
14.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
Ann Rheum Dis
; 79(6): 685-699, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31969328
15.
Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools.
Clin Exp Rheumatol
; 38(6): 1056-1067, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33253107
16.
Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial.
Lancet
; 391(10139): 2513-2524, 2018 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29908670
17.
Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis. Reply.
N Engl J Med
; 384(1): 83-84, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33406337
18.
Early and late responses in patients with rheumatoid arthritis who were conventional synthetic disease-modifying anti-rheumatic drug inadequate responders and were treated with tocilizumab or switched to rituximab: an open-label phase 3 trial (MIRAI).
Clin Exp Rheumatol
; 37(6): 937-945, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31025930
19.
Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial.
Ann Rheum Dis
; 76(7): 1279-1284, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28389552
20.
A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis.
Ann Rheum Dis
; 76(6): 1020-1030, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28213566